Enanta Pharmaceuticals Ratios (2012-2025) | ENTA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)	-144.82%	-154.50%	-141.65%	-109.05%	-179.48%	-165.03%	-129.62%	-123.04%	-211.37%	-184.44%	-155.91%	-189.02%	-184.82%	-128.28%	-199.81%	-133.89%	-160.45%	-99.52%	-123.42%	-64.00%
EBIT Margin (Quarter)	-147.53%	-156.53%	-143.06%	-109.99%	-180.85%	-167.05%	-133.13%	-127.25%	-221.70%	-194.33%	-163.90%	-193.78%	-192.13%	-134.58%	-204.38%	-138.82%	-164.32%	-103.16%	-121.56%	-60.45%
EBITDA Margin (Quarter)	-147.53%	-156.53%	-143.06%	-109.99%	-180.85%	-167.05%	-133.13%	-127.25%	-221.70%	-194.33%	-163.90%	-193.78%	-192.13%	-134.58%	-204.38%	-138.82%	-164.32%	-103.16%	-121.56%	-60.45%
Operating Margin (Quarter)	-147.53%	-156.53%	-143.06%	-109.99%	-180.85%	-167.05%	-133.13%	-127.25%	-221.70%	-194.33%	-163.90%	-193.78%	-192.13%	-134.58%	-204.38%	-138.82%	-164.32%	-103.16%	-121.56%	-60.45%
Net Margin (Quarter)	-180.14%	-111.10%	-347.41%	-108.92%	-179.48%	-162.74%	-131.82%	-122.90%	-211.62%	-206.78%	-146.88%	-185.56%	-182.70%	-126.08%	-210.58%	-131.43%	-151.71%	-99.68%	-122.90%	-64.13%
FCF Margin (Quarter)	-24.02%	-135.05%	-92.28%	-48.17%	-141.61%	-154.61%	-79.05%	-164.50%	-90.85%	-181.45%	-121.33%	-143.17%	-177.49%	-118.62%	-47.92%	-150.63%	-107.37%	149.57%	-33.67%	-63.62%
Efficiency
Assets Average (Quarter)	474.39M	459.10M	444.61M	439.69M	423.71M	396.02M	380.31M	361.47M	336.99M	410.81M	478.72M	445.39M	421.03M	406.19M	387.74M	362.65M	335.82M	312.01M	290.88M	305.12M
Equity Average (Quarter)	444.01M	426.94M	408.64M	391.91M	371.48M	348.30M	329.68M	311.09M	285.11M	253.60M	227.28M	204.31M	179.00M	157.51M	138.86M	120.31M	102.68M	86.41M	72.00M	95.65M
Invested Capital (Quarter)	436.03M	417.85M	399.43M	384.38M	358.58M	338.02M	321.33M	300.84M	269.38M	237.82M	216.74M	191.88M	166.11M	148.91M	128.81M	111.82M	93.54M	79.28M	64.72M	126.59M
Asset Utilization Ratio (Quarter)	0.20	0.21	0.22	0.21	0.22	0.23	0.23	0.23	0.24	0.20	0.17	0.17	0.17	0.18	0.17	0.18	0.19	0.21	0.22	0.22
Leverage & Solvency
Interest Coverage Ratio (Quarter)										-18.38	-9.85	-10.14	-12.78	-10.27	-11.57	-12.00	-14.31	-11.68	-7.70	-3.65
Equity Ratio (Quarter)	0.93	0.93	0.91	0.87	0.88	0.88	0.86	0.87	0.83	0.48	0.47	0.45	0.40	0.37	0.34	0.32	0.29	0.26	0.23	0.38
Times Interest Earned (Quarter)										-18.38	-9.85	-10.14	-12.78	-10.27	-11.57	-12.00	-14.31	-11.68	-7.70	-3.65
Valuation
Enterprise Value (Quarter)	-375.95M	-256.82M	-244.00M	-259.05M	-280.33M	-253.29M	-249.23M	-214.47M	-210.08M	-386.58M	-369.91M	-337.15M	-300.31M	-36.38M	-37.84M	-84.96M	-193.38M	-204.11M	-188.86M	-185.85M
Return Ratios
Return on Sales (Quarter)	-0.02%	-0.01%	-0.03%	-0.01%	-0.02%	-0.02%	-0.01%	-0.01%	-0.02%	-0.02%	-0.01%	-0.02%	-0.02%	-0.01%	-0.02%	-0.01%	-0.02%	-0.01%	-0.01%	-0.01%
Return on Capital Employed (Quarter)	-18.90%	-22.21%	-26.83%	-31.78%	-33.55%	-34.99%	-35.34%	-36.47%	-42.34%	-38.88%	-32.99%	-37.10%	-36.95%	-35.31%	-36.85%	-35.19%	-35.23%	-36.20%	-35.22%	-28.06%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Enanta Pharmaceuticals Ratios (2012-2025) | ENTA

Create an account

Sign In

Reset Password